NP
INSM icon

NorthRock Partners’s Insmed INSM Stock Holding History

NorthRock Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
3,082
-26
-0.8% -$3.15K ﹤0.01% 511
2026
Q1 		$508K Sell
3,108
-10
-0.3% -$1.54K 0.01% 415
2025
Q4 		$543K Buy
+3,118
New +$569K 0.01% 354

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

NorthRock Partners's INSM Position: Q2 2026 in Review

NorthRock Partners reduced its Insmed (INSM) stake by 0.84% in Q2 2026, selling an estimated $3.15K and leaving 3,082 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #511.

NorthRock Partners first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $543K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • NorthRock Partners held 3,082 shares of Insmed worth $329K as of Q2 2026.
  • NorthRock Partners sold 26 Insmed shares in Q2 2026, an estimated $3.15K.
  • Insmed made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #511 holding.
  • NorthRock Partners first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • NorthRock Partners's Insmed position peaked at $543K in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.